Search
Find exactly what you’re looking for.
Search

Section
Topics
Industry
Service
Insights
Series
Location
Showing 41-41 of 41 results

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...
For More Information
Contact us